利格列汀对小鼠脑缺血/再灌注损伤的神经保护作用*

doi:10.12047/j.cjap.6001.2020.096

中国应用生理学杂志 ›› 2020, Vol. 36 ›› Issue (5): 452-455.doi: 10.12047/j.cjap.6001.2020.096

利格列汀对小鼠脑缺血/再灌注损伤的神经保护作用^*

赵波¹, 魏海萍^2△

1.甘肃省平凉市第二人民医院神经内科, 平凉 744000;
2.兰州大学第二医院神经内科, 兰州 730030

收稿日期:2020-01-06 修回日期:2020-07-24 发布日期:2021-02-25
通讯作者: ^△Tel: 15117243002; E-mail: haipingwei11@sina.com
基金资助:
^*兰州大学第二医院萃英科技创新计划应用基础研究(CY2018-QN04)

Neuroprotective effects of linagliptin on ischemia/reperfusion in mice

ZHAO Bo¹, WEI Hai-ping^2△

1. Department of Neurology, the Second People's Hospital of Pingliang City, Pingliang 744000;
2. Department of Neurology, the Second Hospital of Lanzhou University, Lanzhou 730030, China

Received:2020-01-06 Revised:2020-07-24 Published:2021-02-25

摘要/Abstract

摘要： 目的: 评估二肽基肽酶4(DPP-4)抑制剂利格列汀对小鼠脑缺血/再灌注(I/R)损伤的神经保护作用。方法: BALB/c小鼠随机分为Sham组、I/R组和利格列汀(2.5、5和10 mg/kg) +I/R组,每组均为8只小鼠。不同剂量利格列汀组小鼠均在I/R前3周连续灌胃给药。采用小鼠脑中动脉闭塞(MCAO)1 h诱导I/R损伤模型,再灌注24 h评估神经功能缺损(n=8)和及梗死体积(n=4);再灌注48 h处死小鼠,检测脑组织中谷胱甘肽(GSH)、丙二醛(MDA)、磷酸化肌醇3激酶(PI3K)、磷酸化蛋白激酶 B(p-Akt)和雷帕霉素靶蛋白(mTOR)含量(n=4)。结果: 与I/R组相比,利他列汀预处理组小鼠再灌注24 h后,神经功能缺损评分和梗死体积明显降低(P＜0.05);小鼠再灌注48 h后,脑内MDA含量明显降低(P＜0.05),而GSH、PI3K、p-Akt和mTOR水平明显升高(P＜0.05)。结论: 利格列汀对I/R小鼠具有神经保护作用,可能是通过激活PI3K/AKT/mTOR通路发挥的作用。

关键词: 利格列汀, 缺血/再灌注损伤, 磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路, 小鼠

Abstract: Objective: To evaluate the neuroprotective effects of linagliptin, a dipeptidyl peptidase-4(DPP-4) inhibitor, on cerebral ischemia/reperfusion(I/R) injury in mice. Methods: BALB/c mice were randomly divided into Sham group, I/R group and linagliptin (2.5, 5 and 10 mg/kg) +I/R group, 8 mice in each group. The mice in the linagliptin group were administrated by gavage 3 weeks before I/R. I/R injury model was induced by MCAO, neurological deficit scores(n=8) and infarct volume(n=4) were assessed 24 h following reperfusion. Forty-eight hours following reperfusion, mice were euthanized, the contents of glutathione (GSH), malondialdehyde (MDA), phosphoinositide 3 kinase (PI3K), phosphoprotein kinase B (p-Akt) and rapamycin target protein (mTOR) in brain tissue were measured (n=4). Results: Compared with the I/R group, the neurological deficit score and infarct volume were significantly decreased in the linagliptin pretreatment group after 24 h reperfusion (P＜0.05); the MDA content in the brain was significantly decreased (P＜0.05), while the GSH, PI3K, p-Akt and mTOR levels were significantly increased (P＜0.05). Conclusion: This study proves that linagliptin exerted a neuroprotective effect in I/R mice, which may be mediated by activation of the PI3K/AKT/mTOR pathway.

Key words: linagliptin, ischemia/reperfusion, PI3K/AKT/mTOR pathway, mice

中图分类号:

R743.31

赵波, 魏海萍. 利格列汀对小鼠脑缺血/再灌注损伤的神经保护作用^*[J]. 中国应用生理学杂志, 2020, 36(5): 452-455.

ZHAO Bo, WEI Hai-ping. Neuroprotective effects of linagliptin on ischemia/reperfusion in mice[J]. CJAP, 2020, 36(5): 452-455.

参考文献

[1] Nguanmoo P, Tanajak P, Kerdphoo S, et al. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats[J]. Toxicol Appl Pharmacol, 2017, 333: 43-50.
[2] Wongchai K, Schlotterer A, Lin J, et al. Protective effects of liraglutide and linagliptin in C. elegans as a new model for glucose-induced neurodegeneration[J]. Horm Metab Res, 2015, 48(1): 70-75.
[3] Chinda K, Sanit J, Chattipakorn S, et al. Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart[J]. Diab Vasc Dis Res, 2014, 11(2): 75-83.
[4] Yang G, Chan PH, Chen J, et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia[J]. Stroke, 1994, 25(1): 165-170.
[5] Hayakawa K, Mishima K, Nozako M, et al. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism[J]. Stroke, 2008, 39(3): 951-958.
[6] 李永荣, 李红. 外源性维生素D对小鼠脑缺血/再灌注神经损伤的保护作用[J]. 中国应用生理学杂志, 2019, 35(4): 300-303.
[7] El Batsh MM, El Batch MM, Shafik NM, et al. Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats[J]. Eur J Pharmacol, 2015, 769: 297-305.
[8] Zhao Q, Cheng X, Wang X, et al. Neuroprotective effect and mechanism of Mu-Xiang-You-Fang on cerebral ischemia-reperfusion injury in rats[J]. J Ethnopharmacol, 2016, 192: 140-147.
[9] Abdelsalam RM, Safar MM. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways[J]. J Neurochem, 2015, 133(5): 700-707.
[10]Pan L, Qin DD, Zhou Y, et al. Preventive treatment of astaxanthin provides neuroprotection through suppression of reactive oxygen species and activation of antioxidant defense pathway after stroke in rats[J]. Brain Res Bull, 2017, 130: 211-220.
[11]Wu J, Wang R, Yang D, et al. Hydrogen postconditioning promotes survival of rat retinal ganglion cells against ischemia/reperfusion injury through the PI3K/Akt pathway[J].Biochem Biophys Res Commun, 2017, 495(4): 2462-2468.
[12]Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease[J]. Cell, 2017, 168(6): 960-976.
[13]Liu Y, Zhang L, Liang J. Activation of the Nrf2 defense pathway contributes to neuroprotective effects of phloretin on oxidative stress injury after cerebral ischemia/reperfusion in rats[J]. J Neurol Sci, 2015, 351(1-2): 88-92.
[14]Yoshino Y, Ishisaka M, Tsujii S, et al. Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling[J]. Biochem Biophysl Res Commun, 2015, 458(2): 274-279.
[15]Huisamen B, Genis A, Marais E, et al. Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats[J]. Cardiovasc Drugs Ther, 2011, 25(1): 13-20.

利格列汀对小鼠脑缺血/再灌注损伤的神经保护作用^*

Neuroprotective effects of linagliptin on ischemia/reperfusion in mice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	姬瑞方, 卞学鹏, 刘蓓蓓, 胡静芸, 薛香莉, 娄淑杰. 抗阻运动对胰岛素抵抗小鼠海马内焦亡相关蛋白的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 456-461.
[2]	肖楚丽, 滕林, 李金成, 肖煦晖, 于旭东. 对香豆酸对慢性束缚应激诱导小鼠抑郁样行为的作用^*[J]. 中国应用生理学杂志, 2020, 36(5): 485-488.
[3]	席雨鑫, 温馨, 矫立杰, 魏亚新, 常贵全, 武韧, 孙凤起, 郝静辉, 李鸿珠. 外源性H₂S对糖尿病小鼠肝纤维化的作用及其机制^*[J]. 中国应用生理学杂志, 2020, 36(4): 318-320.
[4]	肖楚丽, 谢一铭, 李金成, 彭丽文, 肖志勇, 于旭东. 对香豆酸上调BDNF及改善慢性束缚应激诱导小鼠记忆障碍的作用^*[J]. 中国应用生理学杂志, 2020, 36(4): 375-378.
[5]	邵小婷, 扈敬, 张欣颖, 赵冰冰, 李思葳, 高萍, 徐长庆, 魏璨. 外源性精胺对糖尿病肾病小鼠肾纤维化的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(3): 207-210.
[6]	刘凯丽, 都新新, 张文琴, 吴亚俐, 王茜, 王春芳, 崔香丽. 过表达miR-31对结肠炎模型小鼠TLR4/NF-κB信号通路及凋亡蛋白的调控[J]. 中国应用生理学杂志, 2020, 36(3): 211-215.
[7]	卢林明, 俞婷婷, 何晓伟, 汤娟, 李先伟. 小剂量辣椒素抗小鼠肺纤维化的作用及其机制[J]. 中国应用生理学杂志, 2020, 36(3): 216-222.
[8]	姜洪波, 董家行, 秦玉飞, 刘佳聪, 姜万举, 李若男, 刘岚慈, 田一丹, 许予明, 杜爱林. 硫氢化钠对脊髓小脑共济失调3型小鼠海马MBP及学习记忆的影响[J]. 中国应用生理学杂志, 2020, 36(3): 235-239.
[9]	方振, 胡西厚, 李康, 韩洁, 田蕾, 闫峻, 张伟, 来文庆, 林本成, 刘晓华, 袭著革. PM_2.5鼻腔滴注致小鼠海马组织损伤的炎性机制[J]. 中国应用生理学杂志, 2020, 36(3): 240-244.
[10]	王锋, 张海峰. 利拉鲁肽联合维生素D对高脂诱导非酒精性脂肪肝小鼠的影响及机制[J]. 中国应用生理学杂志, 2020, 36(3): 261-264.
[11]	姚楠, 韦凌霞, 王志旺, 丁茂鹏, 付晓艳, 庞亚蓉, 程小丽, 蔺兴遥, 邵晶. 当归对阴虚哮喘小鼠气道黏液高分泌及TNF-α/NF-κB信号通路的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 97-100.
[12]	霍海燕, 王瑾, 张许梅, 张文婷, 岳继萍, 焦向英. 糖尿病诱导硫氧还蛋白相互作用蛋白(TXNIP)对小鼠胰岛β细胞衰老的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 119-123.
[13]	罗维, 艾磊, 王博发, 王俐颖, 甘彦明, 周越. 高糖条件下小鼠巨噬细胞对骨骼肌细胞成肌分化和胰岛素敏感性的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 124-129.
[14]	赵洋, 杨胜昌, 于富洋, 李文雅, 吉恩生. 消痰化瘀利窍方对慢性间歇性低氧小鼠认知障碍的改善作用^*[J]. 中国应用生理学杂志, 2020, 36(2): 143-147.
[15]	梁宛伶, 肖天保, 袁峰, 曹一波, 颜登国. miRNA-95靶向FOXD1基因对结直肠癌LoVo细胞放射敏感性的影响及其机制^*[J]. 中国应用生理学杂志, 2020, 36(2): 148-151.